Report Detail
Global G-CSF Biosimilars Market Insights, Forecast to 2025
- RnM3480119 |
- 31 May, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
Company profiles are primarily based on public domain information including company
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Pfizer
Novartis
Roche
The global G-CSF Biosimilars market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the G-CSF Biosimilars market based on company, product type, end user and key regions.
This report studies the global market size of G-CSF Biosimilars in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of G-CSF Biosimilars in these regions.
This research report categorizes the global G-CSF Biosimilars market by top players/brands, region, type and end user. This report also studies the global G-CSF Biosimilars market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Market size by Product
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Market size by End User
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global G-CSF Biosimilars market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of G-CSF Biosimilars market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global G-CSF Biosimilars companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of G-CSF Biosimilars submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of G-CSF Biosimilars are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of G-CSF Biosimilars market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 G-CSF Biosimilars Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global G-CSF Biosimilars Market Size Growth Rate by Product
- 1.4.2 Human Growth Hormone
- 1.4.3 Erythropoietin
- 1.4.4 Monoclonal Antibodies
- 1.4.5 Insulin
- 1.4.6 Interferon
- 1.4.7 Granulocyte-Colony Stimulating Factor
- 1.5 Market by End User
- 1.5.1 Global G-CSF Biosimilars Market Size Growth Rate by End User
- 1.5.2 Blood Disorders
- 1.5.3 Oncology Diseases
- 1.5.4 Chronic And Autoimmune Diseases
- 1.5.5 Growth Hormone Deficiencies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global G-CSF Biosimilars Market Size
- 2.1.1 Global G-CSF Biosimilars Revenue 2014-2025
- 2.1.2 Global G-CSF Biosimilars Sales 2014-2025
- 2.2 G-CSF Biosimilars Growth Rate by Regions
- 2.2.1 Global G-CSF Biosimilars Sales by Regions
- 2.2.2 Global G-CSF Biosimilars Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 G-CSF Biosimilars Sales by Manufacturers
- 3.1.1 G-CSF Biosimilars Sales by Manufacturers
- 3.1.2 G-CSF Biosimilars Sales Market Share by Manufacturers
- 3.1.3 Global G-CSF Biosimilars Market Concentration Ratio (CR5 and HHI)
- 3.2 G-CSF Biosimilars Revenue by Manufacturers
- 3.2.1 G-CSF Biosimilars Revenue by Manufacturers (2014-2019)
- 3.2.2 G-CSF Biosimilars Revenue Share by Manufacturers (2014-2019)
- 3.3 G-CSF Biosimilars Price by Manufacturers
- 3.4 G-CSF Biosimilars Manufacturing Base Distribution, Product Types
- 3.4.1 G-CSF Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers G-CSF Biosimilars Product Type
- 3.4.3 Date of International Manufacturers Enter into G-CSF Biosimilars Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global G-CSF Biosimilars Sales by Product
- 4.2 Global G-CSF Biosimilars Revenue by Product
- 4.3 G-CSF Biosimilars Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global G-CSF Biosimilars Breakdown Data by End User
6 North America
- 6.1 North America G-CSF Biosimilars by Countries
- 6.1.1 North America G-CSF Biosimilars Sales by Countries
- 6.1.2 North America G-CSF Biosimilars Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America G-CSF Biosimilars by Product
- 6.3 North America G-CSF Biosimilars by End User
7 Europe
- 7.1 Europe G-CSF Biosimilars by Countries
- 7.1.1 Europe G-CSF Biosimilars Sales by Countries
- 7.1.2 Europe G-CSF Biosimilars Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe G-CSF Biosimilars by Product
- 7.3 Europe G-CSF Biosimilars by End User
8 Asia Pacific
- 8.1 Asia Pacific G-CSF Biosimilars by Countries
- 8.1.1 Asia Pacific G-CSF Biosimilars Sales by Countries
- 8.1.2 Asia Pacific G-CSF Biosimilars Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific G-CSF Biosimilars by Product
- 8.3 Asia Pacific G-CSF Biosimilars by End User
9 Central & South America
- 9.1 Central & South America G-CSF Biosimilars by Countries
- 9.1.1 Central & South America G-CSF Biosimilars Sales by Countries
- 9.1.2 Central & South America G-CSF Biosimilars Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America G-CSF Biosimilars by Product
- 9.3 Central & South America G-CSF Biosimilars by End User
10 Middle East and Africa
- 10.1 Middle East and Africa G-CSF Biosimilars by Countries
- 10.1.1 Middle East and Africa G-CSF Biosimilars Sales by Countries
- 10.1.2 Middle East and Africa G-CSF Biosimilars Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa G-CSF Biosimilars by Product
- 10.3 Middle East and Africa G-CSF Biosimilars by End User
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pfizer G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pfizer G-CSF Biosimilars Products Offered
- 11.1.5 Pfizer Recent Development
- 11.2 Novartis
- 11.2.1 Novartis Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Novartis G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Novartis G-CSF Biosimilars Products Offered
- 11.2.5 Novartis Recent Development
- 11.3 Roche
- 11.3.1 Roche Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Roche G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Roche G-CSF Biosimilars Products Offered
- 11.3.5 Roche Recent Development
- 11.4 Merck & Co.
- 11.4.1 Merck & Co. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Merck & Co. G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Merck & Co. G-CSF Biosimilars Products Offered
- 11.4.5 Merck & Co. Recent Development
- 11.5 Sanofi
- 11.5.1 Sanofi Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Sanofi G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Sanofi G-CSF Biosimilars Products Offered
- 11.5.5 Sanofi Recent Development
- 11.6 Johnson & Johnson
- 11.6.1 Johnson & Johnson Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Johnson & Johnson G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Johnson & Johnson G-CSF Biosimilars Products Offered
- 11.6.5 Johnson & Johnson Recent Development
- 11.7 Gilead Science
- 11.7.1 Gilead Science Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Gilead Science G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Gilead Science G-CSF Biosimilars Products Offered
- 11.7.5 Gilead Science Recent Development
- 11.8 GlaxoSmithKline
- 11.8.1 GlaxoSmithKline Company Details
- 11.8.2 Company Business Overview
- 11.8.3 GlaxoSmithKline G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 GlaxoSmithKline G-CSF Biosimilars Products Offered
- 11.8.5 GlaxoSmithKline Recent Development
- 11.9 AbbVie
- 11.9.1 AbbVie Company Details
- 11.9.2 Company Business Overview
- 11.9.3 AbbVie G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 AbbVie G-CSF Biosimilars Products Offered
- 11.9.5 AbbVie Recent Development
- 11.10 Amgen
- 11.10.1 Amgen Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Amgen G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Amgen G-CSF Biosimilars Products Offered
- 11.10.5 Amgen Recent Development
- 11.11 AstraZeneca
- 11.12 Bayer
12 Future Forecast
- 12.1 G-CSF Biosimilars Market Forecast by Regions
- 12.1.1 Global G-CSF Biosimilars Sales Forecast by Regions 2019-2025
- 12.1.2 Global G-CSF Biosimilars Revenue Forecast by Regions 2019-2025
- 12.2 G-CSF Biosimilars Market Forecast by Product
- 12.2.1 Global G-CSF Biosimilars Sales Forecast by Product 2019-2025
- 12.2.2 Global G-CSF Biosimilars Revenue Forecast by Product 2019-2025
- 12.3 G-CSF Biosimilars Market Forecast by End User
- 12.4 North America G-CSF Biosimilars Forecast
- 12.5 Europe G-CSF Biosimilars Forecast
- 12.6 Asia Pacific G-CSF Biosimilars Forecast
- 12.7 Central & South America G-CSF Biosimilars Forecast
- 12.8 Middle East and Africa G-CSF Biosimilars Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 G-CSF Biosimilars Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on G-CSF Biosimilars . Industry analysis & Market Report on G-CSF Biosimilars is a syndicated market report, published as Global G-CSF Biosimilars Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of G-CSF Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
